NVIDIA is joining with Schrödinger to further expand the speed and accuracy of its computational platform; collaborating with AstraZeneca to develop a transformer-based generative AI model for chemical structures; and teaming up with UF Health, the University of Florida (UF)’s academic health center, to apply what the partners say is the largest clinical language model developed to date for drug discovery as well as clinical medicine . . .

Get GEN Edge Today!

The post From Model to Molecule: NVIDIA Doubles Down on AI Drug Discovery appeared first on GEN – Genetic Engineering and Biotechnology News.